Americans who purchased specific generic drugs between May 1, 2009, and December 31, 2019, may qualify for direct payments from a settlement reached in a class action lawsuit. The settlement resolves allegations that Sun Pharmaceuticals and Taro Pharmaceuticals conspired to raise fixed prices on generic drugs, resulting in higher costs for consumers.